Developing methacrylate-based copolymers as an artificial Bruch's membrane substitute.


Age-related macular degeneration (AMD) is the most common cause of blindness in the developed world. There is currently no treatment for the cellular loss, which is characteristic of AMD. Transplantation of retinal pigment epithelium (RPE) cells represents a potential therapy. Because of AMD-related pathology in the native support, Bruch's membrane… (More)
DOI: 10.1002/jbm.a.34178